Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effects of Resistance Exercise Timing on Midday Muscle Performance in Athletes

23 de setembro de 2026 atualizado por: Manisa Celal Bayar University

Time-Course Effect of Post-Activation Performance Enhancement on Midday Peak Torque and Muscle Activation

This study investigated whether the timing of a resistance-based post-activation performance enhancement (PAPE) intervention performed during the morning influences muscle performance and muscle electrical activity during a standardized midday assessment in trained male athletes. Participants completed a control condition and three PAPE conditions performed at different times during the morning. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises. In all conditions, muscle performance was assessed between 12:00 and 12:15 using an isokinetic dynamometer, while surface electromyography (sEMG) of the rectus femoris muscle was recorded. The study compared relative peak torque and sEMG spectral power across the different PAPE timing conditions and the control condition.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Real)

13

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Manisa, Turquia (Türkiye), 45040
        • Manisa Celal Bayar University, Faculty of Sport Sciences

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Macho

Descrição

Inclusion Criteria:

  • Regularly participating in systematic sport-specific training (minimum training age of 3 years)
  • Able to comply with pre-testing restrictions (avoidance of intense physical activity for 72 hours and caffeine for 2 hours prior to testing sessions)

Exclusion Criteria:

  • Any musculoskeletal, orthopedic, or health condition preventing safe participation in maximal isokinetic exercise testing
  • Current or recent injury affecting lower-limb strength or performance testing

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição cruzada
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Control (C)

Participants completed the standardized midday isokinetic performance assessment without a PAPE intervention. The assessment consisted of four maximal repetitions on an isokinetic dynamometer at 60°·s-¹ between 12:00 and 12:15, while rectus femoris surface electromyography was recorded.

Experimental: PAPE T1

Participants performed the standardized PAPE intervention between 08:00 and 09:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Experimental: PAPE T2

Participants performed the standardized PAPE intervention between 10:00 and 11:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Experimental: PAPE T3

Participants performed the standardized PAPE intervention between 11:45 and 12:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Relative Peak Torque (RPT)
Prazo: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Relative peak torque (RPT) was determined from the highest peak torque value obtained during four maximal knee extension repetitions performed on an isokinetic dynamometer at 60°·s-¹. Peak torque was normalized to body mass and expressed as N·m·kg-¹.

Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.
Rectus Femoris sEMG Spectral Power
Prazo: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Surface electromyography (sEMG) of the rectus femoris muscle was recorded during the maximal isokinetic knee extension repetitions. Spectral power was calculated from the processed sEMG signal using fast Fourier transform (FFT) analysis and expressed as µV²/Hz.

Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

3 de junho de 2025

Conclusão Primária (Real)

20 de agosto de 2025

Conclusão do estudo (Real)

15 de setembro de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

15 de setembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

23 de setembro de 2026

Primeira postagem (Real)

25 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

25 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • MCBU_PAPE_2025

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data are not planned to be publicly shared due to participant confidentiality and data protection considerations.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .